Eric J.G. Sijbrands
0000-0001-8857-7389
Publication & Citation Trends
Publications
0 total
Replication of 10 novel loci involved in human plasma protein N-glycosylation using MALDI-MS and UHPLC-FD data
Cited by 0
Semantic Scholar
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification. OA
Cited by 3
Semantic Scholar
From In Vitro Efficacy to Long‐Term HbA1c Response for GLP‐1R/GlucagonR Agonism Using the 4GI‐HbA1c Systems Model
Cited by 0
Semantic Scholar
Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations OA
Cited by 16
Semantic Scholar
Quantification of the effect of GLP‐1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model OA
Cited by 1
Semantic Scholar
Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes OA
Cited by 11
Semantic Scholar
Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. OA
Cited by 57
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(155)
Diabetes, Cardiovascular Risks, and Lipoproteins
(79)
Genetic Associations and Epidemiology
(63)
Cancer, Lipids, and Metabolism
(54)
Lipid metabolism and disorders
(28)
Affiliations
Ontario Institute for Cancer Research
Agency for Science, Technology and Research
Leiden University
Merck & Co., Inc., Rahway, NJ, USA (United States)
Medpace (United States)